FIL Ltd
Source: SEC Form 13F · as of Mar 2026FIL Ltd holds 20 biotech & pharma companies tracked by BioSniper, totaling $974.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$974.8M
BioSniper AIPage context preserved
Prepared research question
What matters most for REGENERON PHARMACEUTICALS, INC. (REGN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| REGNREGENERON PHARMACEUTICALS, INC. | 309,509 | $239.1M |
| FOLDAMICUS THERAPEUTICS, INC. | 12,560,028 | $181.6M |
| INSMINSMED Inc | 828,947 | $135.5M |
| GILDGILEAD SCIENCES, INC. | 875,527 | $122.0M |
| TEVATeva Pharmaceutical Industries Limited | 3,694,634 | $111.3M |
| DAWNDay One Biopharmaceuticals, Inc. | 4,131,907 | $88.6M |
| APLSApellis Pharmaceuticals, Inc. | 1,140,000 | $45.9M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 91,499 | $30.3M |
| BCAXBicara Therapeutics Inc. | 679,904 | $13.5M |
| SPRYARS Pharmaceuticals, Inc. | 455,575 | $3.7M |
| INCYIncyte Corp. | 21,689 | $2.0M |
| RNAAtrium Therapeutics Inc. | 78,500 | $1.0M |
| RVMDREVOLUTION MEDICINES, INC. | 1,234 | $120K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 880 | $49K |
| IONSIONIS PHARMACEUTICALS INC | 165 | $12K |
| APGEApogee Therapeutics, Inc. | 105 | $9K |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 217 | $7K |
| NUVLNuvalent, Inc. | 65 | $7K |
| SMMTSummit Therapeutics Inc. | 345 | $7K |
| BBIOBridgeBio Pharma, Inc. | 88 | $7K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.